Why improvement in survival of screen-detected cases is not necessarily equivalent to benefit?

被引：5

作者：

de Koning, HJ ^{[1
]}

机构：

[1] Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands

来源：

BREAST | 2003年 / 12卷 / 05期

关键词：

D O I：

10.1016/S0960-9776(03)00128-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：299 / 301

页数：3

共 16 条

[1]

Alexander FE, 1999, EUR J CANCER, V35, P262

[2]

[Anonymous], 2002, IARC HDB CANC PREV

[3] Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality [J].

Blanks, RG ;

Moss, SM ;

McGahan, CE ;

Quinn, MJ ;

Babb, PJ .

BRITISH MEDICAL JOURNAL, 2000, 321 (7262) :665-669

[4] Stage distribution at first and repeat examinations in breast cancer screening [J].

Boer, R ;

de Koning, H ;

van Oortmarssen, G ;

Warmerdam, P ;

van der Maas, P .

JOURNAL OF MEDICAL SCREENING, 1999, 6 (03) :132-138

[5]

DEKONING HJ, 1995, JNCI-J NATL CANCER I, V87, P1217

[6] Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].

Draisma, G ;

Boer, R ;

Otto, SJ ;

van der Cruijsen, IW ;

Damhuis, RAM ;

Schröder, FH ;

de Koning, HJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878

[7] Is screening for breast cancer with mammography justifiable? [J].

Gotzsche, PC ;

Olsen, O .

LANCET, 2000, 355 (9198) :129-134

[8]

Hakama M, 1997, BRIT MED J, V314, P864

[9]

KONING HJ, 2000, LANCET, V335, P80

[10] Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up [J].

Marcus, PM ;

Bergstralh, EJ ;

Fagerstrom, RM ;

Williams, DE ;

Fontana, R ;

Taylor, WF ;

Prorok, PC .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1308-1316

← 1 2 →